Our data may provide an explanation for the possible role of IL-34 in the development of HBV-HCC, i.e., IL-34 regulates differentiation of HBV-HCC, which would have potential clinical relevance regarding IL-34 as a therapeutic target for malignancy. The gene discussed is IL34; the disease is hepatocellular carcinoma.